Centre for Medicines Optimisation Logo
  • Home
  • News
  • About
  • KINES Evidence Service
  • ScriptSwitch® KINE Profile Content Library
  • CCG Subscribers
  • NPC Archive
  • Contact
  • Register
  • Log In
  • Menu

Category Archives: Schizophrenia

NPC Archive Item: Long-acting injectable risperidone no better than oral antipsychotics in unstable schizophrenia

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 6th April 2011 A study has found that, in high-risk patients with schizophrenia and schizoaffective disorder, long-acting injectable risperidone did not significantly improve time to hospitalisation, psychiatric symptoms, quality […]

NPC Archive Item: Aripiprazole in schizophrenia: how does it compare with olanzapine and risperidone▼?

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22 February 2010 A Cochrane review suggests that aripiprazole may be slightly less efficacious than olanzapine and similar to risperidone▼ in the treatment of schizophrenia. However, the clinical significance […]

Categories

  • Antimicrobial prescribing
  • Biosimilars
  • Breastfeeding
  • Cardiovascular disease
  • CKD
  • CNS and mental health
  • Commissioning
  • Common infections
  • Community pharmacy
  • Compliance & concordance
  • Controlled drugs
  • COVID-19
  • Dementia
  • Developing people & organisations
  • Diabetes
  • Drug Safety
  • Epilepsy
  • Evidence informed decision-making (EIDM)
  • Gastro-intestinal
  • General
  • Hormonal Contraceptives
  • Hormone replacement therapy (HRT)
  • Hypertension
  • Improvement skills and tools
  • Increasing efficiency and reducing waste
  • Influenza
  • Insomnia
  • Lifestyle
  • Lipids
  • Local decision-making (LDM)
  • Medicines management
  • Monthly News Updates
  • Monthly Script
  • Musculoskeletal pain
  • Neurodiversity
  • New medicines
  • Non-medical prescribing
  • Obesity
  • Osteoporosis
  • Other therapeutics
  • Pain
  • Palliative care
  • Patient safety and risk
  • People and their medicines
  • Podcasts
  • Polypharmacy
  • QIPP
  • Respiratory
  • Review of medicines
  • Rheumatoid arthritis
  • Schizophrenia
  • Shared decision making
  • Skin conditions
  • Smoking cessation
  • Supplements
  • Venous thromboembolism
  • Wound care

CFMO Terms & Conditions

Conditions of Use

Centre for Medicines Optimisation, Keele University, Keele, Staffordshire, ST5 5BG